Cerebral Infarcts and Vasculopathy in Tanzanian Children With Sickle Cell Anemia

Mboka Jacob1, Dawn E Saunders2, Raphael Z Sangeda3

  • 1Department of Radiology & Imaging, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.

Pediatric Neurology
|March 1, 2020
PubMed

Insights

Silent cerebral infarcts (SCI) and vasculopathy are common in African children with sickle cell anemia (SCA). Vasculopathy increases SCI risk, with anemia and hemolysis as key risk factors.

Area of Science:

  • Neurology
  • Pediatrics
  • Hematology

Background:

  • Cerebral infarcts and vasculopathy in children with sickle cell anemia (SCA) are understudied in African settings.
  • Silent cerebral infarcts (SCI) and vasculopathy can occur in neurologically asymptomatic children with SCA.

Purpose of the Study:

  • To determine the prevalence of SCI and vasculopathy in children with SCA in Africa.
  • To investigate associations between SCI/vasculopathy and chronic hemolysis, anemia, and hypoxia.

Main Methods:

  • Prospective study of 224 children with SCA.
  • Utilized transcranial Doppler (TCD), MRI, and MRA for assessment.
  • Performed regression analyses with hemoglobin, reticulocyte count, oxygen content, and bilirubin levels.

Main Results:

  • SCI prevalence was 27%; vasculopathy (stenosis/occlusion) was present in 17%.
  • SCI was associated with vasculopathy (OR 2.68) and elevated indirect bilirubin.
  • Vasculopathy correlated with prior hemoglobin, oxygen content, reticulocytes, and indirect bilirubin levels.

Conclusions:

  • SCI and vasculopathy are prevalent in African children with SCA, even with normal TCD.
  • Children with vasculopathy face a higher risk of SCI.
  • Chronic anemia, hypoxia, and hemolysis are identified as risk factors for vasculopathy.
Abstract

Related Concept Videos